User: Genecampaign Topic: IP
Category: patent-legal-regime :: india
Last updated: May 04 2013 01:39 IST RSS 2.0
 
1 to 20 of 1,117    
Dealing with a cussed Pakistan (Cached) 4.5.2013 TOI: Editorial
Dealing with a cussed Pakistan
Also found in: [+]
License for Manufacturing Generic Anti-Cancer Drugs (Cached) 30.4.2013 Govt of india: PIB
License for Manufacturing Generic Anti-Cancer Drugs

Also found in: [+]
Little support for pharma MNCs on patent issue (Cached) 27.4.2013 TOI: Intl Business
Multinational drug companies that are complaining against the Indian government and patent authorities using flexibilities under the World Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property rights are finding little support in the international community.
Also found in: [+]
India refutes US criticism of its FDI, IPR laws (Cached) 13.4.2013 Rediff: Business
USTR has said India imposed several barriers in major services industries such as insurance, banking, audiovisual, accounting, legal, telecommunications, distribution services, postal and express delivery services.
Also found in: [+]
Should pharma MNCs be peeved? (Cached) 12.4.2013 Rediff: Business
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Also found in: [+]
Should pharma MNCs be peeved? (Cached) 12.4.2013 Rediff: Columns
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Also found in: [+]
Indian patent rulings may face legal heat internationally (Cached) 11.4.2013 ET: Policy
Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India
Also found in: [+]
Novartis case:Supreme Court ruling wise and balanced (Cached) 10.4.2013 Rediff: Interviews
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]
'Novartis ruling: It is not an anti-patent judgement' (Cached) 10.4.2013 Rediff: Business
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]
Column: What was the Novartis case really about? (Cached) 8.4.2013 Rediff: Business
The drug Glivec was a genuinely new and important discovery deserving of patent protection.
Also found in: [+]
What was the Novartis case really about? (Cached) 8.4.2013 Rediff: Columns
The drug Glivec was a genuinely new and important discovery deserving of patent protection.
Also found in: [+]
Most big patented drugs skip India (Cached) 8.4.2013 TOI: Home
Big pharma may be crying hoarse over India’s “weak’’ intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country.
Also found in: [+]
VIDEO: Patent dilemma for India drugs firms 7.4.2013 BBC: Business
India introduced a new patent law in 2005, under which several multinational pharmaceutical firms have been denied protection for their medicines.
Also found in: [+]
Company profits depend on the 'welfare payments' they get from society | Ha-Joon Chang 5.4.2013 Guardian: Comment is Free
The free market is a myth. From drug patents to quantitative easing, businesses make money because of state help Earlier this week, India's supreme court ruled that the country will not grant a patent to Novartis , the Swiss pharmaceutical company, for the cancer drug, Glivec. Being a new version of an existing drug, the ruling said, it does not deliver enough innovation to warrant a patent. Novartis condemned the ruling as "a setback for patients that will hinder medical progress for diseases without effective treatment options". This statement is rich coming from a company from Switzerland – a country that infamously had no patent law until 1888, half a century after its introduction in most rich capitalist countries. Even after 1888, Switzerland refused to award pharmaceutical and other chemical patents for two decades, the new patent law having stipulated that patents are granted only to "inventions that can be represented by mechanical models". The country introduced chemical patents ...
Also found in: [+]
Japan's Nikkei jumps above 13,000 (Cached) 5.4.2013 TOI: Intl Business
Japan's benchmark stock index surged above 13,000 for the first time in more than four years on Friday.
Also found in: [+]
Initial Cyprus plan to tax insured depositors 'not smart': ECB (Cached) 4.4.2013 TOI: Intl Business
European central Bank President Mario Dragi said on Thursday that Cyprus's initial decision to charge a levy on insured as well as uninsured banks depositors was a mistake.
Also found in: [+]
US jobless claims at four-month high, cast shadow over labor market 4.4.2013 Top Headlines - The Times of India
US jobless claims at four-month high, cast shadow over labor market
Also found in: [+]
Wal-Mart strains to keep aisles stocked fresh (Cached) 4.4.2013 TOI: Home
The retailer is facing low customer confidence after it cut so many workers that it cannot stock its shelves properly, according to some employees and industry analysts.
Also found in: [+]
Japan's central bank shocks with massive stimulus (Cached) 4.4.2013 TOI: Home
The Bank of Japan shocked markets on Thursday with a radical overhaul of its policymaking, adopting a new balance sheet target and pledging to double its government bond holdings in two years as it seeks to end nearly two decades of deflation.
Also found in: [+]
EU, Australia, Canada may follow India's Patent Law (Cached) 4.4.2013 TOI: India
EU, Australia, Canada may follow India's Patent Law
Also found in: [+]
1 to 20 of 1,117